Author

Yanina Jeanne Leona Jansen

Universitair Ziekenhuis LeuvenORCID 0000-0002-8322-9841Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1 Organism:mouse· 1 Assay:proteomics· 1 Assay:scRNA-seq· 1

Frequent Co-Authors

Cleo GoyvaertsiD· 1 shared Daliya KanchevaiD· 1 shared Evelyn Calderon-EspinosaiD· 1 shared Isabelle ScheyltjensiD· 1 shared Kathleen Van den Eynde· 1 shared Kiavash MovahediiD· 1 shared Kim De VeirmaniD· 1 shared Kirsten De RidderiD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

Cleo GoyvaertsORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Lung cancer-fueled emergency myelopoiesis is characterized by an increase of S100A9+ and LCN2+ hematopoietic stem and progenitor cells

Evelyn Calderon-Espinosa, Kirsten De Ridder, Mekhin Carpentier, Kim De Veirman, Daliya Kancheva, Isabelle Scheyltjens, Kiavash Movahedi, Kathleen Van den Eynde, Paul De Leyn, Lieven Depypere, Sophie Hernot, Yanina Jeanne Leona Jansen, Cleo Goyvaerts

This study identifies S100A9 and LCN2 as key regulators in lung cancer-induced myelopoiesis, showing their therapeutic potential in immunotherapy-resistant lung cancer.

bioRxiv · Feb 25, 2026 · PreprintImmunology